Search clinical trials for: %5B18F%5DNOS
Total 0 results
Nothing found
Sponsors and Collaborators
- Eurotrials Brasil Consultores Cientificos Ltda
- S-Biotek Holding ApS
- Lilly PharmaceuticalCompany
- Arsha Vidya Tirtha
- Julian Taylor Green
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Korea Otsuka International Asia Arab
- Plethora Solutions Ltd
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Rivierduinen, Centre for Personality disorders Jelgersma
- Iyad Naeem Muhammad, PhD
- Sudimplant SAS - Groupe TBR
- United States Department of Defense (DOD)
- Oblikue Consulting
- Gunkang Pharmaceuticals, Inc
- Foshan Sanshui District People's Hospital
- Paulo Sérgio Gomes Nogueira Borges
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- University of Applied Sciences Jena
- View Full List
Medical Conditions
- Advance Directive Completion
- Serum Albumin Low
- Deformity Flexion
- Testicular Teratoma
- Gray Platelet Syndrome
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Chemotherapy-Induced Neutropenia
- Visual Attention Span Deficit
- Brain Tumor, Primary
- Malaria,Falciparum
- Vibration; Exposure
- Blepharospasm of Both Eyelids
- Anemia Acute
- Puberty, Delayed
- Thyroid and Parathyroid Surgery
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Hypothermia Following Anesthesia, Sequela
- Immunologically-induced Lung Disease
- Huntington Chorea
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- View Full List
Drug Interventions
- Vosaroxin
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Pegfilgrastim
- Pemetrexed
- Cyanoacrylate
- Oxycodone
- Furmonertinib 160 mg
- Acalabrutinib in combination with VR
- Bimatoprost 0.03% eye drops
- Standard medical therapy
- Celecoxib
- ABY-035 i.v.
- Rovalpituzumab tesirine
- Sorafenib
- S-Adenosyl-Methionine
- F520
- Mineralocorticoid receptor antagonist
- Cytisine
- MMV390048 120mg
- Ebselen
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Canada
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Gambia
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Kenya
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Malta
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Nigeria
- CRO list by country